cbdMD, Inc. Common Stock (YCBD) — Analysis Summary
cbdMD, Inc. Common Stock (YCBD) has a market cap of $7.16M with year-over-year revenue growth of -1.5%. Net margin stands at -10.6%. The stock trades at a P/E ratio of -2.7.
Key Takeaways
- Revenue changed -1.5% year-over-year
- Net margin of -10.6%
- P/E ratio of -2.7
Compared to other companies in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS sector, YCBD posted revenue growth of -1.5% and trades at a P/E of -2.7.
cbdMD, Inc. Common Stock (YCBD)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -126.2x — earnings do not cover interest payments
Operating margin at -13.4% — material operating losses
The latest filing shows negative free cash flow.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Sector
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Employees
42
Headquarters
CHARLOTTE, NC
Exchange
XASE
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.